In the largest study to date on the effects of the drugs on the kidneys, researchers found GLP-1s help the protect the organs ...

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...

This may be the first Thanksgiving for millions of Americans who are on GLP-1 agonists like Ozempic, Zepbound or Wegovy.

For the 12% of adults in the U.S. now taking a weight-loss medication that targets the GLP-1 and/or GIP hormones to restrict ...

“I love Thanksgiving for the pumpkin pie — it's such a low-sugar dessert that it tends to be fine for your blood sugar,” ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid ...

The Biden administration is set to propose legislation allowing Medicare and Medicaid to cover the cost of GLP-1 obesity meds ...

The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other ...

In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...

The new rule would expand access to the drugs for 3.4 million Americans who use Medicare and another 4 million people ...

As use of GLP-1 weight loss drugs including Wegovy and Ozempic increases, brands are introducing new offerings.

The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board ...